Cephalon CEO Frank Baldino: An Interview With “The Pink Sheet” DAILY
This article was originally published in The Pink Sheet Daily
Executive Summary
Cephalon’s chief exec talks about the March PDUFA date for Nuvigil, generic drug settlements and the launch of Fentora.
You may also be interested in...
Cephalon Fentora sNDA In Non-Cancer Pain Slated For Fourth Quarter
The firm is analyzing Phase III data to determine the specific claim to pursue.
Cephalon Fentora sNDA In Non-Cancer Pain Slated For Fourth Quarter
The firm is analyzing Phase III data to determine the specific claim to pursue.
FDA Approves Cephalon’s Nuvigil With Bolded Warning For Rash
Company tells “The Pink Sheet” DAILY it is set to begin studies in other therapeutic areas to boost labeling before commercial launch.